Pancreatic cancer cell genetics and signaling response to treatment correlate with efficacy of gemcitabine-based molecular targeting strategies. [electronic resource]
Producer: 20080724Description: 288-96 p. digitalISSN:- 1091-255X
- Adenocarcinoma -- drug therapy
- Antimetabolites, Antineoplastic -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Blotting, Western
- Cell Proliferation -- drug effects
- Chromones -- administration & dosage
- Curcumin -- administration & dosage
- Deoxycytidine -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Synergism
- Drug Therapy, Combination
- Electrophoretic Mobility Shift Assay
- Enzyme Inhibitors -- administration & dosage
- Humans
- MAP Kinase Signaling System -- drug effects
- Morpholines -- administration & dosage
- NF-kappa B -- drug effects
- Pancreatic Neoplasms -- drug therapy
- Proto-Oncogene Proteins c-akt -- drug effects
- Tumor Cells, Cultured
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.